{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:51:20Z","timestamp":1768413080358,"version":"3.49.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T00:00:00Z","timestamp":1694304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery Case Reports"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ijscr.2023.108819","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:25:15Z","timestamp":1694633115000},"page":"108819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Very rare metastatic phenomena of biliary tract cancer to the cerebellum: A case report and review of the literature"],"prefix":"10.1097","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-1544","authenticated-orcid":false,"given":"Oadi N.","family":"Shrateh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shadi Abu","family":"Saa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"14","key":"10.1016\/j.ijscr.2023.108819_bb0005","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.3748\/wjg.v21.i14.4121","article-title":"Optimum chemotherapy for the management of advanced biliary tract cancer","volume":"21","author":"Ghosn","year":"2015","journal-title":"World J Gastroenterol: WJG"},{"issue":"18","key":"10.1016\/j.ijscr.2023.108819_bb0010","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","article-title":"Biliary tract cancers","volume":"341","author":"de Groen","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijscr.2023.108819_bb0015","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3904\/kjim.2013.28.5.515","article-title":"Current status of chemotherapy for the treatment of advanced biliary tract cancer","volume":"28","author":"Sasaki","year":"2013","journal-title":"Korean J. Intern. Med."},{"issue":"1","key":"10.1016\/j.ijscr.2023.108819_bb0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdn533","article-title":"Epidemiology of biliary tract cancers: an update","volume":"20","author":"Randi","year":"2009","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.ijscr.2023.108819_bb0025","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.7314\/APJCP.2012.13.5.1995","article-title":"Brain metastases from cholangiocarcinoma: a first case series in Thailand","volume":"13","author":"Chindaprasirt","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"10.1016\/j.ijscr.2023.108819_bb0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000479929","article-title":"Brain metastases from biliary tract cancer: a monocentric retrospective analysis of 450 patients","volume":"94","author":"Frega","year":"2018","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.ijscr.2023.108819_bb0035","article-title":"Isolated brain metastasis in cholangiocarcinoma: a case report and review of literature","volume":"78","author":"Kilbourn","year":"2014","journal-title":"Conn. Med."},{"key":"10.1016\/j.ijscr.2023.108819_bb0040","article-title":"Cholangiocarcinoma and brain lesions: an extremely rare finding","volume":"2013","author":"Mirrakhimov","year":"2013","journal-title":"Case Rep."},{"issue":"4","key":"10.1016\/j.ijscr.2023.108819_bb0045","first-page":"144","article-title":"Brain metastasis and leptomeningeal carcinomatosis in a patient with cholangiocarcinoma","volume":"4","author":"William","year":"2011","journal-title":"Gastrointest. Cancer Res.: GCR"},{"issue":"6","key":"10.1016\/j.ijscr.2023.108819_bb0050","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3892\/mco.2017.1253","article-title":"Isolated brain metastases prior to locoregional recurrence in hilar cholangiocarcinoma","volume":"6","author":"Yu","year":"2017","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.ijscr.2023.108819_bb0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijsu.2020.10.034","article-title":"The SCARE 2020 guideline: updating consensus surgical CAse REport (SCARE) guidelines","volume":"84","author":"Agha","year":"2020","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.ijscr.2023.108819_bb0060","first-page":"1545","article-title":"New and emerging treatment options for biliary tract cancer","author":"Noel","year":"2013","journal-title":"Onco. Targets. Ther."},{"issue":"3","key":"10.1016\/j.ijscr.2023.108819_bb0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4143\/crt.2014.308","article-title":"Gemcitabine plus cisplatin for advanced biliary tract cancer: a systematic review","volume":"47","author":"Park","year":"2015","journal-title":"Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.ijscr.2023.108819_bb0070","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2015.11.017","article-title":"Cholangiocarcinoma: current opinion on clinical practice diagnostic and therapeutic algorithms: a review of the literature and a long-standing experience of a referral center","volume":"48","author":"Brandi","year":"2016","journal-title":"Dig. Liver Dis."},{"issue":"14","key":"10.1016\/j.ijscr.2023.108819_bb0075","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ijscr.2023.108819_bb0080","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/bjc.2014.190","article-title":"Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer","volume":"110","author":"Fornaro","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijscr.2023.108819_bb0085","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdr375","article-title":"Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"22","author":"Eckel","year":"2011","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.ijscr.2023.108819_bb0090","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1634\/theoncologist.2015-0356","article-title":"Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients","volume":"21","author":"Brandi","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.ijscr.2023.108819_bb0095","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.4_suppl.225","article-title":"Gemox versus surveillance following surgery of localized biliary tract cancer: results of the PRODIGE 12-ACCORD 18 (UNICANCER GI) phase III trial","author":"Edeline","year":"2017","journal-title":"Proc. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ijscr.2023.108819_bb0100","series-title":"Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","author":"Horgan","year":"2012"},{"issue":"18","key":"10.1016\/j.ijscr.2023.108819_bb0105","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","article-title":"Biliary tract cancers","volume":"341","author":"De Groen","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijscr.2023.108819_bb0110","first-page":"911","article-title":"Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case\u2013control analysis","volume":"24","author":"Brandi","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.ijscr.2023.108819_bb0115","first-page":"4655","article-title":"Recent trends in epidemiology of brain metastases: an overview","volume":"32","author":"Tabouret","year":"2012","journal-title":"Anticancer Res."},{"issue":"10","key":"10.1016\/j.ijscr.2023.108819_bb0120","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/cncr.10541","article-title":"Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma","volume":"94","author":"Schouten","year":"2002","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.ijscr.2023.108819_bb0125","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1002\/cncr.25940","article-title":"Gastrointestinal cancer and brain metastasis: a rare and ominous sign","volume":"117","author":"Go","year":"2011","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ijscr.2023.108819_bb0130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<711::AID-CNCR3>3.0.CO;2-H","article-title":"Brain metastases from colorectal carcinoma: the long term survivors","volume":"78","author":"Farnell","year":"1996","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.ijscr.2023.108819_bb0135","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.3748\/wjg.v10.i22.3345","article-title":"Patients with brain metastases from gastrointestinal tract cancer treated with whole brain radiation therapy: prognostic factors and survival","volume":"10","author":"Bartelt","year":"2004","journal-title":"World J Gastroenterol: WJG"},{"issue":"5","key":"10.1016\/j.ijscr.2023.108819_bb0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1634\/theoncologist.2019-0306","article-title":"Brain metastases from biliary tract cancers: a case series and review of the literature in the genomic era","volume":"25","author":"D\u2019Andrea","year":"2020","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.ijscr.2023.108819_bb0145","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ijscr.2023.108819_bb0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1713137","article-title":"Osimertinib in untreated EGFR-mutated advanced non\u2013small-cell lung cancer","volume":"378","author":"Soria","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ijscr.2023.108819_bb0155","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin\u2013paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"27","key":"10.1016\/j.ijscr.2023.108819_bb0160","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1200\/JCO.2012.44.2806","article-title":"Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations","volume":"31","author":"Sequist","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ijscr.2023.108819_bb0165","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw279","article-title":"Gefitinib or erlotinib vs chemotherapy for EGFR mutation-positive lung cancer: individual patient data meta-analysis of overall survival","volume":"109","author":"Lee","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.ijscr.2023.108819_bb0170","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","article-title":"Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial","volume":"18","author":"Davies","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijscr.2023.108819_bb0175","first-page":"1","article-title":"Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases","author":"Juloori","year":"2019","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ijscr.2023.108819_bb0180","author":"Oncology"},{"issue":"7","key":"10.1016\/j.ijscr.2023.108819_bb0185","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1517\/17425247.2013.808184","article-title":"Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide","volume":"10","author":"Chacko","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"issue":"23","key":"10.1016\/j.ijscr.2023.108819_bb0190","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1158\/1078-0432.CCR-10-1564","article-title":"Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer","volume":"16","author":"Lockman","year":"2010","journal-title":"Clin. Cancer Res."}],"container-title":["International Journal of Surgery Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261223009483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210261223009483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:36:49Z","timestamp":1768387009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210261223009483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":38,"alternative-id":["S2210261223009483"],"URL":"https:\/\/doi.org\/10.1016\/j.ijscr.2023.108819","relation":{},"ISSN":["2210-2612"],"issn-type":[{"value":"2210-2612","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Very rare metastatic phenomena of biliary tract cancer to the cerebellum: A case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijscr.2023.108819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108819"}}